Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Change in Inventory (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Change in Inventory data on record, last reported at -$199000.0 in Q4 2025.

  • For Q4 2025, Change in Inventory fell 514.58% year-over-year to -$199000.0; the TTM value through Dec 2025 reached -$971000.0, down 164.6%, while the annual FY2025 figure was -$971000.0, 164.6% down from the prior year.
  • Change in Inventory reached -$199000.0 in Q4 2025 per TLSI's latest filing, up from -$531000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $915000.0 in Q4 2023 and bottomed at -$531000.0 in Q3 2025.
  • Average Change in Inventory over 4 years is $137692.3, with a median of $114000.0 recorded in 2025.
  • Peak YoY movement for Change in Inventory: soared 419.63% in 2024, then tumbled 514.58% in 2025.
  • A 4-year view of Change in Inventory shows it stood at $185000.0 in 2022, then soared by 394.59% to $915000.0 in 2023, then plummeted by 94.75% to $48000.0 in 2024, then crashed by 514.58% to -$199000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were -$199000.0 in Q4 2025, -$531000.0 in Q3 2025, and -$355000.0 in Q2 2025.